Home › Muscular Dystrophy
Muscular Dystrophy clinical trials recruiting in the U.S.
27 studies for Muscular Dystrophy are recruiting participants at sites across the United States.
Muscular dystrophy (MD) is characterized by progressive weakness and muscle damage. Read about who it affects and the prognosis.
Cities with the most studies
- Washington, DC8 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Sacramento, CA4 studies
- Gainesville, FL3 studies
- Little Rock, AR3 studies
- Durham, NC3 studies
- Mountain View, CA3 studies
By state
- Arkansas3 studies
- California6 studies
- District of Columbia4 studies
- Florida3 studies
- Illinois4 studies
- Maryland5 studies
- Massachusetts4 studies
- New York3 studies
- North Carolina4 studies
- Texas4 studies
Recently updated studies
Study of Inherited Neurological Disorders
RecruitingObservational study
Ages 2 to 120 · All sexes · Updated Sep 28, 2026 · NCT00004568Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
RecruitingObservational study
Ages 2 and older · Men · Updated Sep 24, 2026 · NCT06564974Investigational Use of Neuromuscular Ultrasound
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 110 · All sexes · Updated Sep 17, 2026 · NCT05237973Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Sep 4, 2026 · NCT07700225Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07521930Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
RecruitingPhase 1
Ages 8 to 18 · Men · Updated Aug 24, 2026 · NCT07172971Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Recruiting
Ages 6 and older · Men · Updated Aug 17, 2026 · NCT07766980Once Weekly Infant Corticosteroid Trial for DMD
RecruitingPhase 4
1 Month – 30 Months · Men · Updated Aug 14, 2026 · NCT05412394Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RecruitingObservational study
Ages 5 to 25 · All sexes · Updated Jul 23, 2026 · NCT06998134A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
RecruitingObservational study
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT07127978PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
RecruitingPhase 1/2
Ages 2 to 7 · Men · Updated Jun 23, 2026 · NCT07429240Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 2, 2026 · NCT05724173BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 1, 2026 · NCT00912041Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
RecruitingPhase 3
Ages 4 to 18 · Men · Updated May 27, 2026 · NCT07608432Duchenne Electronic Health Record Study
RecruitingObservational study
All ages · All sexes · Updated May 27, 2026 · NCT07609394Vasodilator and Exercise Study for DMD (VASO-REx)
RecruitingPhase 2
Ages 6 and older · Men · Updated May 15, 2026 · NCT06290713Nomad P-KAFO Study
Recruiting
Ages 18 to 89 · All sexes · Updated May 11, 2026 · NCT05644522The Duchenne Registry
RecruitingObservational study
All ages · All sexes · Updated May 8, 2026 · NCT02069756ECoG BMI for Motor and Speech Control
Recruiting
Ages 21 and older · All sexes · Updated May 5, 2026 · NCT03698149Muscle Health Measurements Using Electrical Impedance Myography
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 89 · All sexes · Updated Apr 3, 2026 · NCT07502989Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07362875Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Recruiting
Ages 18 to 80 · All sexes · Updated Dec 1, 2025 · NCT06094205Long-Term Development of Muscular Dystrophy Outcome Assessments
RecruitingObservational study
Ages 6 to 50 · All sexes · Updated Nov 18, 2025 · NCT05989620Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
Recruiting
Ages 3 to 17 · All sexes · Updated Oct 27, 2025 · NCT05726591Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.